Today's presentation at Cantor Fitzgerald Global Healthcare Conference | DVAX Message Board Posts

Dynavax Technologies Corporation

  DVAX website

DVAX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1240 of 1648  at  10/1/2018 2:43:52 PM  by

fairvalueforyou


 In response to msg 1239 by  liuyiiv
view thread

Re: Today's presentation at Cantor Fitzgerald Global Healthcare Conference

As we discussed earlier, I am very hopeful about a positive AZD1419 trial data because AstraZeneca just confirmed that some AZD1419 trial patients, for example, the last 14 patients enrolled between 9/20/2018 and 12/20/2018, have lasted for at least 9 months so far not to meet its primary endpoint.
Also, there is need to gather the data for how long AZD1419 treatment effect would last, therefore, AZD1419 trial could have been extended for those patients in the treatment group.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 146
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...